Haw ParHAWPF 95 Interest Coverage is 45.88 as of Dec. 2025, which is 75% below its 10-year median of 183.84. GuruFocus rates HAWPF with a GF Score™ of 95/100 and a GF Value™ of $8.79. The stock has 3 warning signs investors should review. Among 685 Drug Manufacturers companies, Haw Par ranks better than 69.78% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Haw Par's
Operating Income
for the
six
months ended in Dec. 2025 was $26.2 Mil. Haw Par's Interest Expense for the
six
months ended in Dec. 2025 was $-0.6 Mil.
Haw Par's interest coverage for the quarter that ended in Dec. 2025 was 45.88.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Haw Par's Interest Coverage or its related term are showing as below:
HAWPF'
s Interest Coverage Range Over the Past 10 Years
Min: 30.62 Med: 183.84 Max: 914.7
Current: 44.05
HAWPF's Interest Coverage is ranked better than 69.78% of 685
companies
in the Drug Manufacturers industry
Industry Median: 12.78
vs HAWPF: 44.05
Haw Par (OTCPK:HAWPF) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Haw Par Interest Coverage Related Terms
Haw Par Interest Coverage Historical Data
* Premium members only.
The historical data trend for Haw Par's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
HAWPF vs LLY, JNJ, ABBV: Interest Coverage Comparison
For the Drug Manufacturers - General subindustry, Haw Par's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Haw Par Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Haw Par's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Haw Par's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Haw Par (HAWPF) has a Interest Coverage of 45.88 as of Dec. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Haw Par and its competitors. This is 75% below median its historical median of 183.84. Over the past decade, Haw Par's Interest Coverage has ranged from 30.62 to 914.70. According to the industry distribution chart, Haw Par ranks #207 out of 685 companies in the Drug Manufacturers industry, placing it in the top 30.2%.
Is Haw Par's Interest Coverage too high?
Haw Par's current Interest Coverage of 45.88 is 75% below median its 10-year median of 183.84. Over the past 10 years, this metric has ranged from a low of 30.62 to a high of 914.70. The Drug Manufacturers industry median Interest Coverage is 12.78. Haw Par's value of 45.88 is 259% above this industry median. Based on the distribution chart, Haw Par ranks #207 out of 685 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Haw Par has a GF Score™ of 95/100, reflecting its overall financial health beyond just this single metric.
How does Haw Par's Interest Coverage compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Haw Par ranks #207 out of 685 companies for Interest Coverage. This puts Haw Par in the upper half of its industry. The industry median Interest Coverage is 12.78. Haw Par's value of 45.88 is 259% above this benchmark. Historically, Haw Par's own Interest Coverage has ranged from 30.62 to 914.70 over the past decade. While the company's 10-year median is 183.84 vs. the industry median of 12.78, Haw Par has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.78, based on 685 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Haw Par's current Interest Coverage of 45.88 is 259% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Haw Par and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Haw Par's current Interest Coverage is 45.88, which is 75% below median its own 10-year median of 183.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Haw Par stock overvalued right now?
Haw Par (HAWPF) has a current Interest Coverage of 45.88. The stock's GF Value™ is $8.79, compared to a current price of $12.00 — trading 36.5% above its estimated fair value. The current Interest Coverage is 45.88, which is 75% below median its 10-year median of 183.84 and 259% above the Drug Manufacturers industry median of 12.78. Haw Par's overall GF Score™ is 95/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Haw Par (HAWPF), the current Interest Coverage is 45.88 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Haw Par (HAWPF) Overvalued in 2026?
Based on GuruFocus' analysis, Haw Par stock appears to be overvalued.
The current stock price of $12.00 is trading 36.5% above its estimated GF Value™ of $8.79.
Key valuation signals for HAWPF:
Interest Coverage: 45.88 (75% below median its 10-year median of 183.84)
GF Value™: $8.79 vs. price of $12.00 (36.5% above fair value)
Industry Position: 259% above the Drug Manufacturers median (#207 of 685)
No single metric tells the full story. See the HAWPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Haw Par Corp Ltd is a drug manufacturing company that operates multiple brands. The company is to expand its core businesses through product brand extension, strategic alliances, and exploring potential acquisitions. Its operating segments include the Healthcare segment, Investments segment, Property segment, and Leisure segment. The company generates the majority of its revenue from the Healthcare segment. Its Healthcare segment manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brands. Geographically, it generates key revenue from the other ASEAN and other Asian countries.
95GF Score
Get the complete analysis for HAWPF
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HAWPF has been successfully added to your 
